Old Web
English
Sign In
Acemap
>
Paper
>
P473 Long-term follow-up of switching from original adalimumab to adalimumab biosimilar: real-world data in IBD
P473 Long-term follow-up of switching from original adalimumab to adalimumab biosimilar: real-world data in IBD
2020
C. Padilla Suárez
K. Webb
N. Persad
J Sercombe
E. Tyler
K Klimova
Keywords:
Adalimumab
Physical therapy
Medicine
Biosimilar
Pediatrics
Biosimilar Pharmaceuticals
real world data
Disease remission
Ulcerative colitis
long term follow up
antidrug antibody
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]